Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.360
+0.350 (17.41%)
At close: Aug 14, 2026, 4:00 PM EDT
2.302
-0.058 (-2.45%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Equillium Employees
As of December 31, 2025, Equillium had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 20 or -57.14% compared to the previous year.
Employees
15
Change (1Y)
-20
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$1,200,600
Market Cap
149.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | -20 | -57.14% | 14 | 1 |
| Dec 31, 2024 | 35 | -9 | -20.45% | 35 | 0 |
| Sep 30, 2024 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2024 | 45 | -2 | -4.26% | 45 | 0 |
| Mar 31, 2024 | 44 | 7 | 18.92% | 44 | 0 |
| Dec 31, 2023 | 44 | 8 | 22.22% | 44 | 0 |
| Sep 30, 2023 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2023 | 47 | 2 | 4.44% | 47 | 0 |
| Mar 31, 2023 | 37 | -10 | -21.28% | 37 | 0 |
| Dec 31, 2022 | 36 | -9 | -20.00% | 36 | 0 |
| Sep 30, 2022 | 45 | 0 | - | 45 | 0 |
| Jun 30, 2022 | 45 | - | - | 45 | 0 |
| Mar 31, 2022 | 47 | 16 | 51.61% | 47 | 0 |
| Dec 31, 2021 | 45 | 14 | 45.16% | 45 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Molecular Partners AG | 134 |
| Milestone Pharmaceuticals | 38 |
| Cue Biopharma | 29 |
| Aardvark Therapeutics | 28 |
| Jyong Biotech | 27 |
| Spruce Biosciences | 22 |
| Unicycive Therapeutics | 22 |
EQ News
- 1 day ago - Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 day ago - Equillium Earnings release: Q2 2026 - Filings
- 1 day ago - Equillium Quarterly report: Q2 2026 - Filings
- 2 days ago - Equillium Slides: Corporate presentation - Filings
- 24 days ago - Equillium initiated with a Buy at Clear Street - TheFly
- 4 weeks ago - Equillium initiated with an Overweight at Piper Sandler - TheFly
- 2 months ago - EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake - Accesswire
- 2 months ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire